Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Chlamydia screening interventions from community pharmacies: a systematic review

Chlamydia screening interventions from community pharmacies: a systematic review Background Chlamydia ( Chlamydia trachomatis ) is the most commonly notified sexually transmissible infection in Australia. Increasing the number of people aged 16–25 years being tested for chlamydia has become a key objective. The strategy recommends that chlamydia screening sites should be easy to access. Community pharmacies are conveniently located and easily accessible. This review aimed to determine the different types of pharmacy-based chlamydia screening interventions, describe their uptake rates, and understand issues around the acceptability of and barriers to testing. Methods : Seven electronic databases were searched for peer-reviewed articles published up to 30 October 2011 for studies that reported chlamydia screening interventions from community pharmacies, or had qualitative evidence on acceptability or barriers linked with interventions. Results : Of the 163 publications identified, 12 met the inclusion criteria. Nine reported chlamydia screening interventions in a pharmacy setting, whereas three focussed on perspectives on chlamydia screening. Pharmacists could offer a chlamydia test to consumers attending the pharmacy for a sexual health-related consultation, or consumers could request a chlamydia test as part of a population-based intervention. Participating consumers said pharmacies were accessible and convenient, and pharmacists were competent when offering a chlamydia test. Pharmacists reported selectively offering tests to women they thought would be most at risk, undermining the principles of opportunistic interventions. Conclusion : Chlamydia screening from community pharmacies is feasible, and can provide an accessible, convenient venue to get a test. Professional implementation support, alongside resources, education and training programs, and incentives may overcome the issue of pharmacists selectively offering the test. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Sexual Health CSIRO Publishing

Chlamydia screening interventions from community pharmacies: a systematic review

Download PDF
11 pages

Loading next page...
 
/lp/csiro-publishing/chlamydia-screening-interventions-from-community-pharmacies-a-xEwqp4PQsw

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
CSIRO Publishing
Copyright
CSIRO
ISSN
1448-5028
eISSN
1449-8987
DOI
10.1071/SH12069
pmid
23651619
Publisher site
See Article on Publisher Site

Abstract

Background Chlamydia ( Chlamydia trachomatis ) is the most commonly notified sexually transmissible infection in Australia. Increasing the number of people aged 16–25 years being tested for chlamydia has become a key objective. The strategy recommends that chlamydia screening sites should be easy to access. Community pharmacies are conveniently located and easily accessible. This review aimed to determine the different types of pharmacy-based chlamydia screening interventions, describe their uptake rates, and understand issues around the acceptability of and barriers to testing. Methods : Seven electronic databases were searched for peer-reviewed articles published up to 30 October 2011 for studies that reported chlamydia screening interventions from community pharmacies, or had qualitative evidence on acceptability or barriers linked with interventions. Results : Of the 163 publications identified, 12 met the inclusion criteria. Nine reported chlamydia screening interventions in a pharmacy setting, whereas three focussed on perspectives on chlamydia screening. Pharmacists could offer a chlamydia test to consumers attending the pharmacy for a sexual health-related consultation, or consumers could request a chlamydia test as part of a population-based intervention. Participating consumers said pharmacies were accessible and convenient, and pharmacists were competent when offering a chlamydia test. Pharmacists reported selectively offering tests to women they thought would be most at risk, undermining the principles of opportunistic interventions. Conclusion : Chlamydia screening from community pharmacies is feasible, and can provide an accessible, convenient venue to get a test. Professional implementation support, alongside resources, education and training programs, and incentives may overcome the issue of pharmacists selectively offering the test.

Journal

Sexual Health – CSIRO Publishing

Published: May 8, 2013

Keywords: acceptability, access, barriers, opportunistic screening, testing.

References

  • Genital chlamydial infections.
    Peipert JF
  • Risk of sequelae after Chlamydia trachomatis genital infection in women.
    Haggerty CL Gottlieb SL Taylor BD Low N Xu F Ness RB
  • Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
    Land JA Van Bergen JE Morre SA Postma MJ
  • The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis : a structured review.
    Risser WL Risser JM
  • Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis.
    Egger M Low N Smith GD Lindblom B Herrmann B
  • Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985–1993: declining rates for how much longer?
    Herrmann B Egger M
  • Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden.
    Kamwendo F Forslin L Bodin L Danielsson D
  • Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening.
    LaMontagne DS Fenton KA Randall S Anderson S Carter P
  • Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.
    van den Broek IV van Bergen JE Brouwers EE Fennema JS Götz HM Hoebe CJ et al
  • Efficacy of home sampling for screening of Chlamydia trachomatis : randomised study.
    Ostergaard L Andersen B Olesen F Moller J
  • Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
    Scholes D Stergachis A Heidrich FE Andrilla H Holmes KK Stamm WE
  • Chlamydia screening – Australia should strive to achieve what others have not.
    Hocking JS Walker J Regan D Chen MY Fairley CK
  • Australian general practitioner chlamydia testing rates among young people.
    Kong F Guy R Hocking J Merritt T Pirotta M Heal C et al
  • Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions.
    Tilson EC Sanchez V Ford CL Smurzynski M Leone PA Fox KK et al
  • Implementing chlamydia screening: what do women think? A systematic review of the literature.
    Pavlin NL Gunn JM Parker R Fairley CK Hocking J
  • “If everyone does it, it’s not a big deal.” Young people talk about chlamydia testing.
    Rose SB Smith MC Lawton BA
  • Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence.
    Anderson C Blenkinsopp A
  • A comparative evaluation of pharmacy services in single and no pharmacy towns.
    Sunderland V Burrows S Joyce A
  • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A Altman DG Tetzlaff J Mulrow C Gotzsche PC Ioannidis JPA et al
  • A pharmacy-based private chlamydia screening programme: results from the first 2 years of screening and treatment.
    Anderson C Thornley T
  • Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London.
    Baraitser P Pearce V Holmes J Horne N Boynton PM
  • Community-based chlamydia and gonorrhea screening through the United States mail, San Francisco.
    Bloomfield PJ Kent C Campbell D Hanbrook L Klausner JD
  • Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study.
    Brabin L Thomas G Hopkins M O’Brien K Roberts SA
  • A trial of the distribution of chlamydia self-collection postal specimen kits from Australian community pharmacies.
    Emmerton L Buhrer Skinner M Gardiner E Nissen L Debattista J
  • Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples.
    van Bergen JEAM Postma MJ Peerbooms PGH Spangenberg AC Tjen-A-Tak J Bindels PJE
  • Acceptance of a chlamydia screening program in community pharmacies.
    Taylor KL Clifford RM Marshall L
  • Chlamydia screening by community pharmacists: a qualitative study.
    Dabrera G Pinson D Whiteman S
  • A qualitative study of pharmacists’ views on offering chlamydia screening to women requesting emergency hormonal contraception.
    Thomas G Humphris G Ozakinci G O’Brien K Roberts SA Hopkins M et al